Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biomedicines|January 21, 2023
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in CancerDzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Journal of Clinical Medicine|July 2, 2021
Cancer Stem Cells as a Source of Drug Resistance in Bone SarcomasSofía T Menéndez, Borja Gallego, Dzohara Murillo, et al.
Free Radical Biology & Medicine|October 16, 2023
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cellsJuan Tornín, Borja Gallego, Verónica Rey, et al.
International Journal of Molecular Sciences|June 24, 2022
Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant ModelsBorja Gallego, Dzohara Murillo, Verónica Rey, et al.
Redox Biology|March 29, 2023
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcomaJuan Tornín, Miguel Mateu-Sanz, Verónica Rey, et al.
Mikrochimica Acta|March 4, 2020
Visual detection of microRNA146a by using RNA-functionalized gold nanoparticlesAdrián Sánchez-Visedo, Borja Gallego, Luis José Royo, et al.
Mikrochimica Acta|July 17, 2023
MNAzymes and gold nanoparticles as isothermal signal amplification strategy for visual detection of miRNAAdrián Sánchez-Visedo, Borja Gallego-Martínez, Luis José Royo, et al.
Scientific Reports|April 28, 2022
Proof of concept for the use of trained sniffer dogs to detect osteosarcomaAgustín Ortal, Aida Rodríguez, María Pilar Solis-Hernández, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 5, 2023
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signalingÓscar Estupiñán, Verónica Rey, Juan Tornín, et al.
Journal of Nanobiotechnology|September 7, 2021
Mithramycin delivery systems to develop effective therapies in sarcomasÓscar Estupiñán, Enrique Niza, Iván Bravo, et al.
Pageof 2